<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00618865</url>
  </required_header>
  <id_info>
    <org_study_id>NSC 93-2320-B-039-001</org_study_id>
    <nct_id>NCT00618865</nct_id>
  </id_info>
  <brief_title>Omega-3 Fatty Acids for Major Depressive Disorder During Pregnancy</brief_title>
  <official_title>Omega-3 Polyunsaturated Fatty Acids in Women With Major Depressive Disorders During Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Science Council, Taiwan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Science Council, Taiwan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Whether high-dose omega-3 fatty acids supplement would be an effective treatment in patients
      with major depressive disorder during pregnancy and breast-feeding.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2004</start_date>
  <completion_date type="Actual">June 2004</completion_date>
  <primary_completion_date type="Actual">June 2004</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>omega-3 fatty acid with 2.2 g of eicosapentanoic acid (EPA) and 1.2 g of docosahexanoic acid (DHA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (olive oil ethyl esters)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Omega-3 fatty acids</intervention_name>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible participants were pregnant women, aged 18 to 40 years, with major depressive
             disorder onset between their 16th week (second trimester) and 32nd week (third
             trimester) of gestation at the Department of Obstetrics.

        Exclusion Criteria:

          -  Subjects were excluded with a DSM-IV diagnosis of bipolar disorders, psychotic
             disorders, substance abuse or dependence for at least 3 months, or any Axis-II
             diagnosis of borderline or antisocial personality disorder.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2008</study_first_submitted>
  <study_first_submitted_qc>February 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2008</study_first_posted>
  <last_update_submitted>February 8, 2008</last_update_submitted>
  <last_update_submitted_qc>February 8, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2008</last_update_posted>
  <responsible_party>
    <name_title>Kuan-Pin Su</name_title>
    <organization>China Medical University Hospital</organization>
  </responsible_party>
  <keyword>Omega-3 Fatty Acids</keyword>
  <keyword>Major Depressive Disorder</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Women during pregnancy and after childbirth are more vulnerable to psychiatric disorders</keyword>
  <keyword>Pharmacotherapy for depression during pregnancy is a clinical dilemma.</keyword>
  <keyword>Omega-3 polyunsaturated fatty acids (PUFAs) might be a promising alternative of treatment for pregnant women with depression.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

